Analyst Upgrades and Downgrades For the Week of June 17th

Friday, June 21st

Upgrades – Friday, June 21, 2024

• Alcoa (AA)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight>>Overweight
  • Price Target: $36.5>>$50
• Buenaventura SA (BVN)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight>>Overweight
  • Price Target: $21
• Freeport-McMoRan (FCX)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight>>Overweight
  • Price Target: $49.5>>$62
• Anglo American (NGLOY)
  • Brokerage Firm: Exane BNP Paribas
  • Ratings Change: Neutral>>Outperform
• NIKE (NKE)
  • Brokerage Firm: Oppenheimer
  • Ratings Change: Perform>>Outperform
  • Price Target: $110>>$120
• Outset Medical (OM)
  • Brokerage Firm: RBC Capital Mkts
  • Ratings Change: Sector Perform>>Outperform
  • Price Target: $5>>$6
• Vale S.A. (VALE)
  • Brokerage Firm: Exane BNP Paribas
  • Ratings Change: Underperform>>Neutral
• Prestige Consumer (PBH)
  • Brokerage Firm: DA Davidson
  • Ratings Change: Neutral>>Buy
  • Price Target: $65>>$93
• PENN Entertainment (PENN)
  • Brokerage Firm: Craig Hallum
  • Ratings Change: Hold>>Buy
  • Price Target: $30

Downgrades – Friday, June 21, 2024

• CME Group (CME)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Neutral>>Underweight
  • Price Target: $206>>$187
• Northrop Grumman (NOC)
  • Brokerage Firm: Bernstein
  • Ratings Change: Outperform>>Mkt Perform
  • Price Target: $477
• Ryanair Holdings (RYAAY)
  • Brokerage Firm: Barclays
  • Ratings Change: Overweight>>Equal Weight
• Vasta Platform (VSTA)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight>>Underweight
  • Price Target: $4.5>>$3
• Palantir Technologies (PLTR)
  • Brokerage Firm: Monness Crespi & Hardt
  • Ratings Change: Neutral>>Sell
  • Price Target: $20
• CGI Group (GIB)
  • Brokerage Firm: CIBC
  • Ratings Change: Sector Outperform>>Neutral

Coverage Initiated – Friday, June 21, 2024

• Audioeye (AEYE)
  • Brokerage Firm: ROTH MKM
  • Ratings Change: Buy
  • Price Target: $25
• BrightSpring Health Services (BTSG)
  • Brokerage Firm: BTIG Research
  • Ratings Change: Buy
  • Price Target: $15
• Choice Hotels (CHH)
  • Brokerage Firm: Susquehanna
  • Ratings Change: Neutral
  • Price Target: $125
• GE Vernova (GEV)
  • Brokerage Firm: Daiwa Securities
  • Ratings Change: Outperform
  • Price Target: $201.5
• Hyatt Hotels (H)
  • Brokerage Firm: Susquehanna
  • Ratings Change: Neutral
  • Price Target: $160
• Hilton (HLT)
  • Brokerage Firm: Susquehanna
  • Ratings Change: Neutral
  • Price Target: $215
• Harmony Biosciences (HRMY)
  • Brokerage Firm: Citigroup
  • Ratings Change: Buy
  • Price Target: $48
• Intchains Group Limited (ICG)
  • Brokerage Firm: The Benchmark Company
  • Ratings Change: Buy
  • Price Target: $10
• ICU Medical (ICUI)
  • Brokerage Firm: Needham
  • Ratings Change: Hold
• Marriott (MAR)
  • Brokerage Firm: Susquehanna
  • Ratings Change: Neutral
  • Price Target: $255
• Matador Resources (MTDR)
  • Brokerage Firm: Stephens
  • Ratings Change: Overweight
  • Price Target: $83
• Palo Alto Networks (PANW)
  • Brokerage Firm: DA Davidson
  • Ratings Change: Buy
  • Price Target: $380
• SM Energy (SM)
  • Brokerage Firm: Stephens
  • Ratings Change: Overweight
  • Price Target: $63
• Viking Holdings Ltd (VIK)
  • Brokerage Firm: Truist
  • Ratings Change: Hold
  • Price Target: $38
• Wyndham Hotels & Resorts (WH)
  • Brokerage Firm: Susquehanna
  • Ratings Change: Neutral
  • Price Target: $80
• CSW Industrials (CSWI)
  • Brokerage Firm: CL King
  • Ratings Change: Buy
• Akoya Biosciences (AKYA)
  • Brokerage Firm: Craig Hallum
  • Ratings Change: Buy
  • Price Target: $7.5

Thursday, June 20th

Upgrades:

• Bread Financial (BFH)
  • Brokerage Firm: Evercore ISI
  • Ratings Change: Underperform >> In-line
  • Price Target: $42 >> $45
• Bilibili (BILI)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Neutral >> Overweight
  • Price Target: $21
• dLocal Limited (DLO)
  • Brokerage Firm: UBS
  • Ratings Change: Sell >> Neutral
  • Price Target: $13 >> $9
• iRhythm (IRTC)
  • Brokerage Firm: Wolfe Research
  • Ratings Change: Peer Perform >> Outperform
  • Price Target: $115
• Ocular Therapeutix (OCUL)
  • Brokerage Firm: TD Cowen
  • Ratings Change: Hold >> Buy
  • Price Target: $7 >> $11
• TransUnion (TRU)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral >> Buy
  • Price Target: $92
• HomeStreet (HMST)
  • Brokerage Firm: Janney
  • Ratings Change: Neutral >> Buy
  • Price Target: $13.5
• Skyworks (SWKS)
  • Brokerage Firm: B. Riley Securities
  • Ratings Change: Neutral >> Buy
  • Price Target: $96 >> $130
• Williams Cos (WMB)
  • Brokerage Firm: Argus
  • Ratings Change: Hold >> Buy
• First Quantum Minerals (FQVLF)
  • Brokerage Firm: Citigroup
  • Ratings Change: Neutral >> Buy
• ASM Intl NV (ASMIY)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight >> Overweight

Downgrades:

• Esperion Therapeutics (ESPR)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral >> Underperform
  • Price Target: $2.5
• Prelude Therapeutics (PRLD)
  • Brokerage Firm: Barclays
  • Ratings Change: Equal Weight >> Underweight
  • Price Target: $3
• Spirit Aerosystems (SPR)
  • Brokerage Firm: The Benchmark Company
  • Ratings Change: Buy >> Hold
• Zentalis Pharma (ZNTL)
  • Brokerage Firm: UBS
  • Ratings Change: Buy >> Neutral
  • Price Target: $28 >> $5
• Wartsila (WRTBY)
  • Brokerage Firm: Deutsche Bank
  • Ratings Change: Buy >> Hold
• Ryanair Hldgs (RYAAY)
  • Brokerage Firm: UBS
  • Ratings Change: Buy >> Neutral
• Deutsche Lufthansa AG (DLAKY)
  • Brokerage Firm: Stifel
  • Ratings Change: Buy >> Hold
• British Land (BTLCY)
  • Brokerage Firm: Stifel
  • Ratings Change: Buy >> Hold

Coverage Initiated:

• ESAB Corp. (ESAB)
  • Brokerage Firm: Oppenheimer
  • Ratings Change: Outperform
  • Price Target: $115
• Samsara (IOT)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Buy
  • Price Target: $37
• Life360 (LIF)
  • Brokerage Firm: JMP Securities
  • Ratings Change: Market Outperform
  • Price Target: $38
• Vericel (VCEL)
  • Brokerage Firm: TD Cowen
  • Ratings Change: Buy
  • Price Target: $55

Coverage Resumed:

• Cardlytics (CDLX)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral
  • Price Target: $11
• MKS Instruments (MKSI)
  • Brokerage Firm: Deutsche Bank
  • Ratings Change: Hold
  • Price Target: $140
• Vodafone PLC (VOD)
  • Brokerage Firm: Deutsche Bank
  • Ratings Change: Buy
• Birkenstock Holding Plc (BIRK)
  • Brokerage Firm: Exane BNP Paribas
  • Ratings Change: Outperform
  • Price Target: $68

Tuesday, June 18th

Upgrades – Tuesday, June 18, 2024:

• Kroger (KR)
  • Brokerage Firm: BMO Capital Markets
  • Ratings Change: Market Perform >> Outperform
  • Price Target: $58 >> $60
• STMicroelectronics (STM)
  • Brokerage Firm: Goldman
  • Ratings Change: Sell >> Neutral
  • Price Target: $35.5 >> $45.8
• Sunoco LP (SUN)
  • Brokerage Firm: Citigroup
  • Ratings Change: Neutral >> Buy
  • Price Target: $65
• Juniper Networks (JNPR)
  • Brokerage Firm: Argus
  • Ratings Change: Hold >> Buy
• QuinStreet (QNST)
  • Brokerage Firm: Craig Hallum
  • Ratings Change: Hold >> Buy
  • Price Target: $22

Downgrades – Tuesday, June 18, 2024:

• Aerovate Therapeutics (AVTE)
  • Wells Fargo: Overweight >> Equal Weight
  • Price Target: $35 >> $2
• Aerovate Therapeutics (AVTE)
  • TD Cowen
  • Ratings Change: Buy >> Hold
• Aerovate Therapeutics (AVTE)
  • Evercore ISI
  • Ratings Change: Outperform >> In-line
  • Price Target: $27 >> $2
• Equitable Holdings (EQH)
  • Brokerage Firm: UBS
  • Ratings Change: Buy >> Neutral
  • Price Target: $40 >> $43
• Ovid Therapeutics (OVID)
  • Brokerage Firm: Oppenheimer
  • Ratings Change: Outperform >> Perform
• First Solar (FSLR)
  • Brokerage Firm: Janney
  • Ratings Change: Buy >> Neutral
• Zentalis Pharma (ZNTL)
  • Wells Fargo
  • Ratings Change: Overweight >> Equal Weight
• Zentalis Pharma (ZNTL)
  • Wedbush
  • Ratings Change: Neutral >> Underperform
  • Price Target: $15 >> $4
• Zentalis Pharma (ZNTL)
  • Morgan Stanley
  • Ratings Change: Overweight >> Equal-Weight
  • Price Target: $38 >> $8
• Zentalis Pharma (ZNTL)
  • Jefferies
  • Ratings Change: Buy >> Hold
  • Price Target: $42 >> $6

Coverage Initiated – Tuesday, June 18, 2024:

• Celldex Therapeutics (CLDX)
  • Brokerage Firm: Stifel
  • Ratings Change: Buy
  • Price Target: $58
• CRH Plc. (CRH)
  • Brokerage Firm: Stephens
  • Ratings Change: Overweight
  • Price Target: $95
• Knife River Corp. (KNF)
  • Brokerage Firm: Stephens
  • Ratings Change: Overweight
  • Price Target: $85
• Omega Therapeutics (OMGA)
  • Brokerage Firm: Raymond James
  • Ratings Change: Outperform
  • Price Target: $12
• Praxis Precision Medicines (PRAX)
  • Brokerage Firm: Guggenheim
  • Ratings Change: Buy
  • Price Target: $155
• Repligen (RGEN)
  • Brokerage Firm: Guggenheim
  • Ratings Change: Neutral
• Third Harmonic Bio (THRD)
  • Brokerage Firm: Stifel
  • Ratings Change: Buy
  • Price Target: $23
• Innoviva (INVA)
  • Brokerage Firm: Cantor Fitzgerald
  • Ratings Change: Overweight
• Pilgrim’s Pride (PPC)
  • Brokerage Firm: Argus
  • Ratings Change: Buy
  • Price Target: $41
• RB Global (RBA)
  • Brokerage Firm: CIBC
  • Ratings Change: Sector Outperform
• Cardlytics (CDLX)
  • Brokerage Firm: Northland Capital
  • Ratings Change: Outperform
  • Price Target: $14

Monday, June 17th

Upgrades

• Best Buy (BBY)
  • Brokerage Firm: UBS
  • Ratings Change: Neutral >> Buy
  • Price Target: $85 >> $106
• Brighthouse Financial (BHF)
  • Brokerage Firm: Keefe Bruyette
  • Ratings Change: Underperform >> Mkt Perform
  • Price Target: $48 >> $47
• Fate Therapeutics (FATE)
  • Brokerage Firm: Piper Sandler
  • Ratings Change: Neutral >> Overweight
  • Price Target: $4 >> $6
• Greif (GEF)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral >> Buy
  • Price Target: $76 >> $77
• Keurig Dr Pepper (KDP)
  • Brokerage Firm: Truist
  • Ratings Change: Sell >> Hold
  • Price Target: $27 >> $34
• Newmont Corporation (NEM)
  • Brokerage Firm: UBS
  • Ratings Change: Neutral >> Buy
  • Price Target: $40 >> $50
• Ollie’s Bargain Outlet (OLLI)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Neutral >> Overweight
  • Price Target: $105
• Public Service (PEG)
  • Brokerage Firm: Guggenheim
  • Ratings Change: Neutral >> Buy
  • Price Target: $82
• Toll Brothers (TOL)
  • Brokerage Firm: Goldman
  • Ratings Change: Sell >> Neutral
  • Price Target: $112 >> $124
• ICU Medical (ICUI)
  • Brokerage Firm: Raymond James
  • Ratings Change: Mkt Perform >> Outperform
  • Price Target: $135
• Itau Unibanco Holding SA (ITUB)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight >> Overweight
• Capri Holdings (CPRI)
  • Brokerage Firm: Citigroup
  • Ratings Change: Neutral >> Buy
  • Price Target: $41
• Corning (GLW)
  • Brokerage Firm: Fox Advisors
  • Ratings Change: Equal Weight >> Overweight
  • Price Target: $45

Downgrades

• Louisiana-Pacific (LPX)
  • Brokerage Firm: Goldman
  • Ratings Change: Neutral >> Sell
  • Price Target: $89 >> $81
• MSC Industrial (MSM)
  • Brokerage Firm: KeyBanc Capital Markets
  • Ratings Change: Overweight >> Sector Weight
• MSC Industrial (MSM)
  • Brokerage Firm: Loop Capital
  • Ratings Change: Buy >> Hold
  • Price Target: $80
• Union Pacific (UNP)
  • Brokerage Firm: Loop Capital
  • Ratings Change: Buy >> Hold
  • Price Target: $276 >> $238
• Shattuck Labs (STTK)
  • Brokerage Firm: BTIG Research
  • Ratings Change: Buy >> Neutral
• Aerovate Therapeutics (AVTE)
  • Brokerage Firm: Wedbush
  • Ratings Change: Outperform >> Neutral
  • Price Target: $41 >> $3
• Aerovate Therapeutics (AVTE)
  • Brokerage Firm: BTIG Research
  • Ratings Change: Buy >> Neutral
• Aerovate Therapeutics (AVTE)
  • Brokerage Firm: Guggenheim
  • Ratings Change: Buy >> Neutral

Coverage Initiated

• Alkermes Plc (ALKS)
  • Brokerage Firm: TD Cowen
  • Ratings Change: Buy
  • Price Target: $34
• Bowhead Specialty Holdings (BOW)
  • Brokerage Firm: Keefe Bruyette
  • Ratings Change: Mkt Perform
  • Price Target: $30
• Bowhead Specialty Holdings (BOW)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight
  • Price Target: $26
• Bowhead Specialty Holdings (BOW)
  • Brokerage Firm: JMP Securities
  • Ratings Change: Mkt Outperform
  • Price Target: $31
• Bowhead Specialty Holdings (BOW)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Neutral
  • Price Target: $27
• Bowhead Specialty Holdings (BOW)
  • Brokerage Firm: RBC Capital Mkts
  • Ratings Change: Outperform
  • Price Target: $32
• Kayne Anderson BDC (KBDC)
  • Brokerage Firm: UBS
  • Ratings Change: Neutral
  • Price Target: $17
• Kayne Anderson BDC (KBDC)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Buy
  • Price Target: $17.5
• Kayne Anderson BDC (KBDC)
  • Brokerage Firm: Keefe Bruyette
  • Ratings Change: Mkt Perform
  • Price Target: $17
• Kayne Anderson BDC (KBDC)
  • Brokerage Firm: RBC Capital Mkts
  • Ratings Change: Outperform
  • Price Target: $17
• Kayne Anderson BDC (KBDC)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $17
• Legend Biotech (LEGN)
  • Brokerage Firm: Truist
  • Ratings Change: Buy
  • Price Target: $88
• Life360 (LIF)
  • Brokerage Firm: Canaccord Genuity
  • Ratings Change: Buy
  • Price Target: $40
• Life360 (LIF)
  • Brokerage Firm: Evercore ISI
  • Ratings Change: Outperform
  • Price Target: $37
• Life360 (LIF)
  • Brokerage Firm: Loop Capital
  • Ratings Change: Buy
  • Price Target: $36
• Lexicon Pharma (LXRX)
  • Brokerage Firm: H.C. Wainwright
  • Ratings Change: Buy
  • Price Target: $10
• Q32 Bio (QTTB)
  • Brokerage Firm: Guggenheim
  • Ratings Change: Buy
  • Price Target: $100
• The Trade Desk (TTD)
  • Brokerage Firm: Wedbush
  • Ratings Change: Outperform
  • Price Target: $110
• Palantir Technologies (PLTR)
  • Brokerage Firm: Argus
  • Ratings Change: Buy
  • Price Target: $29
• Veralto (VLTO)
  • Brokerage Firm: TD Cowen
  • Ratings Change: Hold
  • Price Target: $95
• Ooma (OOMA)
  • Brokerage Firm: Lake Street
  • Ratings Change: Buy
  • Price Target: $14
• Pagaya (PGY)
  • Brokerage Firm: Keefe Bruyette
  • Ratings Change: Outperform
  • Price Target: $23
• Nayax Ltd. (NYAX)
  • Brokerage Firm: Keefe Bruyette
  • Ratings Change: Mkt Perform
  • Price Target: $27